Cryo-Cell International Operating Income

As of the most recent data (May 2026), CCEL shows a operating income of $-100K. That compares with $3.8M in the prior-year period — down 102.7% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, CCEL's operating income is now $-100K (was $3.8M) — a 102.7% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Cryo-Cell International is outperforming or lagging.

Tracking CCEL's operating income over time shows whether Cryo-Cell International is scaling, shrinking, or reshaping that part of the business. The current reading is $-100K That compares with $3.8M in the prior-year period — down 102.7% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this operating income page, Stockcircle has Cryo-Cell International's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect operating income (currently $-100K) with ownership activity and broader fundamentals.

Cryo-Cell International's operating income is $-100K; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.